Is a complete AIM/CLBX research report available?

No complete published report is available for aim/CLBX (AIM/CLBX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/CLBX (AIM/CLBX)

London Stock Exchange AIM: AIM/CLBX · GBX

GBX 1.20

+0.10 (+8.7%)· Recorded snapshot

Market cap	12.5M
Revenue (ttm)	1.2M
Net income (ttm)	-12.9M
EPS (ttm)	-GBX 0.02
Shares out	1.1B
Volume	219,548
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2M
Net income (ttm): -12.9M
EPS (ttm): -GBX 0.02
Market cap: 12.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All AIM/CLBX indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

GBP

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	114
Employees Change	-5%
Employees Change Percent	-4.2
Enterprise value	GBX 10.9M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	GB0034330679
Last refreshed	2026-09-11
Market cap	GBX 12.5M
Price	GBX 1.2
Price currency	GBX
Rev Per Employee	10,105.26x
Sector	Healthcare
Sector PE	21.2
Sector PE Fwd	13.53
Sic	3845
Symbol	aim/CLBX
Website	https://cellbxhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-103.53%
EV/Sales	9.49x
FCF yield	-70.6%
P/B ratio	3.04x
P/S ratio	10.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-28.91%
Gross Profit	GBX -333,000
Gross Profit Growth Q	-21.89%
Net Income	GBX -12.9M
Pretax Margin	-1,071.61%
Profit Per Employee	GBX -113,526
ROA	-37.24
Roa5y	-33.8
ROCE	-143.5
ROE	-163.8
Roe5y	-75.8
ROIC	-46.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-32.77%
Cagr15y	-18.8%
Cagr1y	-71.21%
Cagr20y	-19.22%
Cagr3y	-57.67%
Cagr5y	-60.01%
Revenue Growth	-56.1x
Revenue Growth Q	-25x
Revenue Growth Qo Q	7.57x
Revenue Growth3 Y	-14.11x
Revenue Growth5 Y	6.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.09
Assets	GBX 7.8M
Cash	GBX 2.9M
Current Assets	GBX 6.2M
Current Liabilities	GBX 2.4M
Debt	GBX 1.3M
Debt Equity	GBX 0.32
Debt FCF	GBX -0.15
Equity	GBX 4.1M
Interest Coverage	-43.09
Liabilities	GBX 3.7M
Long Term Assets	GBX 1.6M
Long Term Liabilities	GBX 1.3M
Net Cash	GBX 1.6M
Net Cash By Market Cap	GBX 12.51
Net Cash Growth	-2.49%
Net Debt Equity	GBX -0.38
Tangible Book Value	GBX 3.8M
Tangible Book Value Per Share	GBX 0
WACC	6.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.54
Inventory Turnover	1.09
Net Working Capital	GBX 1.3M
Quick ratio	2.07
Working Capital	GBX 3.7M
Working Capital Turnover	GBX 0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-135.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.11%
1Y total return	-71.18%
200-day SMA	1.19
3Y total return	-92.42%
50-day SMA	1.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-98.98%
All Time High	175
All Time High Change	-99.32%
All Time High Date	2005-02-21
All Time Low	0.85
All Time Low Change	40.71%
All Time Low Date	2026-01-14
ATR	0.1
Beta	0.41
Beta1y	0.63
Beta2y	0.2
Ch YTD	8.73
High	1.2
High52	4.29
High52 Date	2025-09-10
High52ch	-75.54%
Low	1.2
Low52	0.85
Low52 Date	2026-05-01
Low52ch	40.71%
Ma50ch	-7.93%
Price vs 200-day SMA	0.17%
RSI	15.52
RSI Monthly	33.98
RSI Weekly	38.22
Sharpe ratio	-0.47x
Sharpe Ratio3y	-0.2x
Sharpe Ratio5y	-0.39x
Sortino ratio	-0.69
Sortino Ratio3y	-0.33
Sortino Ratio5y	-0.65
Total Return	-135.82%
Tr YTD	8.73
Tr15y	-95.6%
Tr1m	-11.41%
Tr1w	4%
Tr3m	-33.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	491,470,007%
Net Borrowing	-753,000
Shares Insiders	16.81%
Shares Institutions	32.74%
Shares Out	1,136,402,658
Shares Qo Q	195.16%
Shares Yo Y	135.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -7.6M
Adjusted OCF	-7,482,000
Average Volume	1,112,615x
Bv Per Share	0
CAPEX	GBX -162,000
Ch10y	-98.12
Ch15y	-95.61
Ch1m	-11.41
Ch1w	4
Ch1y	-71.18
Ch20y	-98.6
Ch3m	-33.56
Ch3y	-92.43
Ch5y	-98.98
Ch6m	32.89
Change	8.73%
Change From Open	0
Close	1.1
Days Gap	8.73
Depreciation Amortization	1,608,000
Dollar Volume	262,579.4
Earnings Date	2026-09-14
EBIT	GBX -7.7M
EBITDA	GBX -6.1M
EPS	GBX -0.02
F Score	1
FCF	GBX -8.8M
FCF EV Yield	-80.69x
FCF Per Share	GBX -0.01
Financing CF	6,446,000
Fiscal Year End	December
Founded	1,994
Income Tax	GBX 597,000
Investing CF	-74,000
Is Primary Listing	1
Last Earnings Date	2026-06-22
Last Report Date	2026-06-30
Ma150	1.23
Ma150ch	-2.61%
Ma20	1.23
Ma20ch	-2.45%
Net CF	-2,395,000
Next Earnings Date	2026-09-14
Open	1.2
Ppne	1,356,000
Price Date	2026-09-10
Ptbv Ratio	3.26
Relative Volume	0.19x
Revenue	1,152,000x
SBC By Revenue	-102.52x
Share Based Comp	-1,181,000
Tax By Revenue	51.82x
Tr20y	-98.6%
Tr6m	32.89%
Volume	219,548
Z Score	-27.89

AIM/CLBX (AIM/CLBX)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/CLBX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/CLBX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/CLBX

Frequently asked questions